title: Label-Free Proteome Analysis of Plasma from Patients with Breast Cancer: Stage-Specific Protein Expression.
abstract: Breast cancer is one of the most commonly diagnosed types of cancer among women. Breast cancer mortality rates remain high probably because its diagnosis is hampered by inaccurate detection methods. Since changes in protein expression as well as modifications in protein glycosylation have been frequently reported in cancer development, the aim of this work was to study the differential expression as well as modifications of glycosylation of proteins from plasma of women with breast cancer at different stages of disease (n= 30) compared to healthy women (n= 10). A proteomics approach was used that depleted albumin and IgG from plasma followed by glycoprotein enrichment using immobilized Moraceae lectin (frutalin)-affinity chromatography and data-independent label-free mass spectrometric analysis. Data are availableviaProteomeXchange with identifier PXD003106. As result, 57,016 peptides and 4,175 proteins among all samples were identified. From this, 40 proteins present in unbound (PI-proteins that did not interact with lectin) and bound (PII-proteins that interacted with lectin) fractions were differentially expressed. High levels of apolipoprotein A-II were detected here that were elevated significantly in the early and advanced stages of the disease. Apolipoprotein C-III was detected in both fractions, and its level was increased slightly in the PI fraction of patients with early-stage breast cancer and expressed at higher levels in the PII fraction of patients with early and intermediate stages. Clusterin was present at higher levels in both fractions of patients with early and intermediate stages of breast cancer. Our findings reveal a correlation between alterations in protein glycosylation, lipid metabolism, and the progression of breast cancer.
authors.affiliation: Department of Biochemistry and Molecular Biology, Federal University of Ceará (UFC), Fortaleza, Brazil; Center of Experimental Biology (Nubex), University of Fortaleza (UNIFOR), Fortaleza, Brazil.
authors.forename: Marina Duarte Pinto
authors.initials: MD
authors.lastname: Lobo
authors.affiliation: Center of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
authors.forename: Frederico Bruno Mendes Batista
authors.initials: FB
authors.lastname: Moreno
authors.affiliation: Mass Spectrometry Applications Research and Development Laboratory, Waters Corporation , São Paulo , Brazil.
authors.forename: Gustavo Henrique Martins Ferreira
authors.initials: GH
authors.lastname: Souza
authors.affiliation: Center of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
authors.forename: Sara Maria Moreira Lima
authors.initials: SM
authors.lastname: Verde
authors.affiliation: Center of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
authors.forename: Renato de Azevedo
authors.initials: RA
authors.lastname: Moreira
authors.affiliation: Center of Experimental Biology (Nubex), University of Fortaleza (UNIFOR) , Fortaleza , Brazil.
authors.forename: Ana Cristina de Oliveira
authors.initials: AC
authors.lastname: Monteiro-Moreira
keywords: MSE; biomarkers; breast cancer; lectin; mass spectrometry